Press Releases
RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award
9 August 2023 -- Pennsylvania, US -- Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023
CluePoints, the premier provider of Risk-Based Study Execution and Risk-Based Quality Management software for clinical trials, is proud to announce its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). The Business Intelligence Group’s prestigious awards programme is designed to recognise those organisations working to solve the challenges of connecting and collaborating with prospects and customers.
RBQMLive is an annual event that brings together RBQM experts, clinical trial specialists and curious listeners to discuss the adoption, utilisation and best practices of risk-based quality management (RBQM) – a system for managing data quality throughout a clinical trial across the pharmaceutical sector. Sponsored and organised by CluePoints, the event takes place online over two days and is free to attend.
Launched following the height of the COVID-19 pandemic in 2021, when travel restrictions where still in place, RBQMLive is a purely educational platform. Each year, the event offers talks from some of the field’s leading minds, all designed to fill educational gaps, illuminate trending topics, provide fresh perspectives and accelerate the adoption of the transformative approach to clinical trial conduct.
Patrick Hughes, co-founder and chief commercial officer of CluePoints, said: “We are delighted to have been recognized by the Business Intelligence Group for our work on RBQMLive and are proud to be in the esteemed company of our fellow Sammys winners. I would like to thank all the CluePoints staff who have worked so hard on making the event a success and a connection point amongst industry peers, which attracted more than 2,000 registered delegates last year. I would also like to thank the commitment of the industry thought leaders who presented at RBQMLive, as without their invaluable knowledge this event wouldn’t have been a success.
“RBQM is a relatively new study management approach. As the first company to bring the technology to the market, we feel we are responsible for educating the industry on its value, implementation and regulatory basis. RBQMLive gives research and pharma professionals from all levels and functions access to some of the top minds in our field in a free, online format that meets the needs of modern professional education. In doing so, it paves the path for our industry at large.”
“We are proud to reward and recognise RBQMLive for their innovation and dedication to helping both the organisation using their technology and the ultimate consumer,” said Maria Jimenez, chief nominations officer of Business Intelligence Group. “It was clear to our judges that their efforts will improve how we connect with the brands we love for years to come.”
Visit: www.rbqmlive.com/
About CluePoints
CluePoints is the premier provider of Risk-Based Study Execution and Data Quality Oversight Software. Our products utilise comprehensive statistical algorithms to determine clinical trial data quality, accuracy and integrity, both during and after study conduct. Aligned with guidance from the FDA, EMA and ICH E6, CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and drive a holistic risk-based strategy in all trials.
9 August 2023 -- Pennsylvania, US -- Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023
CluePoints, the premier provider of Risk-Based Study Execution and Risk-Based Quality Management software for clinical trials, is proud to announce its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). The Business Intelligence Group’s prestigious awards programme is designed to recognise those organisations working to solve the challenges of connecting and collaborating with prospects and customers.
RBQMLive is an annual event that brings together RBQM experts, clinical trial specialists and curious listeners to discuss the adoption, utilisation and best practices of risk-based quality management (RBQM) – a system for managing data quality throughout a clinical trial across the pharmaceutical sector. Sponsored and organised by CluePoints, the event takes place online over two days and is free to attend.
Launched following the height of the COVID-19 pandemic in 2021, when travel restrictions where still in place, RBQMLive is a purely educational platform. Each year, the event offers talks from some of the field’s leading minds, all designed to fill educational gaps, illuminate trending topics, provide fresh perspectives and accelerate the adoption of the transformative approach to clinical trial conduct.
Patrick Hughes, co-founder and chief commercial officer of CluePoints, said: “We are delighted to have been recognized by the Business Intelligence Group for our work on RBQMLive and are proud to be in the esteemed company of our fellow Sammys winners. I would like to thank all the CluePoints staff who have worked so hard on making the event a success and a connection point amongst industry peers, which attracted more than 2,000 registered delegates last year. I would also like to thank the commitment of the industry thought leaders who presented at RBQMLive, as without their invaluable knowledge this event wouldn’t have been a success.
“RBQM is a relatively new study management approach. As the first company to bring the technology to the market, we feel we are responsible for educating the industry on its value, implementation and regulatory basis. RBQMLive gives research and pharma professionals from all levels and functions access to some of the top minds in our field in a free, online format that meets the needs of modern professional education. In doing so, it paves the path for our industry at large.”
“We are proud to reward and recognise RBQMLive for their innovation and dedication to helping both the organisation using their technology and the ultimate consumer,” said Maria Jimenez, chief nominations officer of Business Intelligence Group. “It was clear to our judges that their efforts will improve how we connect with the brands we love for years to come.”
Visit: www.rbqmlive.com/
About CluePoints
CluePoints is the premier provider of Risk-Based Study Execution and Data Quality Oversight Software. Our products utilise comprehensive statistical algorithms to determine clinical trial data quality, accuracy and integrity, both during and after study conduct. Aligned with guidance from the FDA, EMA and ICH E6, CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and drive a holistic risk-based strategy in all trials.
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.